2nd Year Activities

Outputs 1430-1431 

 
1- Continuing to implement a preliminary applications on patients using the active substance (pilot study) after finishing the first phase of clinical trials.

2 - We have successfully finished most of the processing requirements of the General Authority for food, medicine community includes the analysis of components of the active material to prove the safety of the boat-to-use human consumption (growth of bacteria, etc.).

3 - made an agreement with the factory for  manufacturing the active substance in the form of pharmaceutical compounds.

4 - Publitiong some scientific papers (listed bellow)

5 - Recording a patent in the European Patent Office covering the European 35-nation  No. 09,162,954.3 on 06.17.2009 has adopted talent.

6 - Recording a patent in the Office of the Chinese Patent No. 200,910,168,793.7 on 3/9/2009.

7 - We got the official approval from the Ethics Committee of Scientific Research at King Abdul Aziz on 10/28/2009 for the application of the drug on human beings - patients

8 - D.Mahmoud Shaheen Al-Ahwal the consultant oncologist at King Abdul Aziz uni.- Jeddah joined the team of  Zamil  Scientific chair Cancer Research 

9-We got the General Authority for Food and Drug Administration to manufacture and sell ointments, gels and lotions, shampoos,   

Ointment number 6261 / G dated 17/3/1431 AH

Gel No. 6259 / G dated 17/3/1431 AH

Lotion No. 6262 / G dated 17/3/1431 AH

Shampoo No. 6260 / G dated 17/3/1431 AH

10 - D.Haifa Janna, the Commission specialist dermatologist in Aziziyah hospital  Jeddah, joined the research team of Al- Zamil  scientific chair for cancer research and to follow up patients with psoriasis - eczema - vitiligo.